Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder (Q74252882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

schizoaffective disorder

1 reference

inferred from title

author name string

Virginija Novak-Grubic

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Rok Tavcar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

148-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

Cantabria first-episode schizophrenia study: three-year follow-up

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Drug refusal in schizophrenia and the wish to be crazy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Recidivism in Slovenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Memory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

The capacity of a measure of disability (the LSP) to predict hospital readmission in those with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Compliance in therapy of schizophrenic patients with neuroleptics--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Compliance, quality assurance and standards for relapse prevention in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Age and other factors relevant to the rehospitalization of schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

One-year outcome of schizophrenic patients--the interaction of chronicity and neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Dropping out of psychiatric treatment: a prospective study of a first-admission cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Determinants of medication compliance in schizophrenia: empirical and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Effect of Patient Education on Medication Compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Clinical symptomatology and drug compliance in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Subjective response to antipsychotic drugs: failure to replicate predictions of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

Awareness of illness in schizophrenia and schizoaffective and mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2802%2900645-4

7 January 2021

10.1016/S0924-9338(02)00645-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12052575%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference